Meiser, P.; Flegel, M.; Holzer, F.; Groß, D.; Steinmetz, C.; Scherer, B.; Jain, R.; CARVIN-II Study Group.
Azelastine Nasal Spray in Non-Hospitalized Subjects with Mild COVID-19 Infection: A Randomized Placebo-Controlled, Parallel-Group, Multicentric, Phase II Clinical Trial. Viruses 2024, 16, 1914.
https://doi.org/10.3390/v16121914
AMA Style
Meiser P, Flegel M, Holzer F, Groß D, Steinmetz C, Scherer B, Jain R, CARVIN-II Study Group.
Azelastine Nasal Spray in Non-Hospitalized Subjects with Mild COVID-19 Infection: A Randomized Placebo-Controlled, Parallel-Group, Multicentric, Phase II Clinical Trial. Viruses. 2024; 16(12):1914.
https://doi.org/10.3390/v16121914
Chicago/Turabian Style
Meiser, Peter, Michael Flegel, Frank Holzer, Dorothea Groß, Charlotte Steinmetz, Barbara Scherer, Rajesh Jain, and CARVIN-II Study Group.
2024. "Azelastine Nasal Spray in Non-Hospitalized Subjects with Mild COVID-19 Infection: A Randomized Placebo-Controlled, Parallel-Group, Multicentric, Phase II Clinical Trial" Viruses 16, no. 12: 1914.
https://doi.org/10.3390/v16121914
APA Style
Meiser, P., Flegel, M., Holzer, F., Groß, D., Steinmetz, C., Scherer, B., Jain, R., & CARVIN-II Study Group.
(2024). Azelastine Nasal Spray in Non-Hospitalized Subjects with Mild COVID-19 Infection: A Randomized Placebo-Controlled, Parallel-Group, Multicentric, Phase II Clinical Trial. Viruses, 16(12), 1914.
https://doi.org/10.3390/v16121914
